Cary Street Partners Investment Advisory LLC Sells 16,640 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cary Street Partners Investment Advisory LLC reduced its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 71.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,777 shares of the pharmacy operator’s stock after selling 16,640 shares during the period. Cary Street Partners Investment Advisory LLC’s holdings in Walgreens Boots Alliance were worth $177,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Highlander Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Venturi Wealth Management LLC boosted its position in shares of Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the period. EverSource Wealth Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 845 shares in the last quarter. Rocky Mountain Advisers LLC bought a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at $30,000. Finally, Planned Solutions Inc. bought a new position in Walgreens Boots Alliance in the 4th quarter worth $34,000. 58.59% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The purchase was disclosed in a legal filing with the SEC, which is available through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. SVB Leerink lowered their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research report on Wednesday, April 3rd. Morgan Stanley lowered their price target on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research report on Monday, April 1st. Truist Financial restated a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Finally, Barclays initiated coverage on Walgreens Boots Alliance in a report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price objective for the company. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $24.36.

Walgreens Boots Alliance Trading Down 2.2 %

Shares of NASDAQ WBA opened at $17.34 on Thursday. The business has a fifty day moving average price of $19.75 and a 200 day moving average price of $21.65. Walgreens Boots Alliance, Inc. has a 1-year low of $17.25 and a 1-year high of $34.60. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The stock has a market capitalization of $14.96 billion, a P/E ratio of -2.48, a price-to-earnings-growth ratio of 1.10 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.16 EPS. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 5.77%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is currently -14.29%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.